Conference News Conference News Daily digests from key neurology conferences, written by on-site medical journalists. Published: Apr 28, 2020

Novel treatment has promising effects on quality of life for patients with Parkinson’s disease

Phase II study results suggest that treatment with the drug-device combination ND0612 may have a positive impact on patient-rated activities of daily living and quality of life in Parkinson’s disease (PD).